New reimbursement approved by the Japanese Ministry of Health, Labor and Welfare for the Accuray CyberKnife system to treat trigeminal neuralgia, a condition often causing severe facial pain

26 October 2022 - Accuray Incorporated announced today that the Japanese MHLW has approved reimbursement for the CyberKnife system for the ...

Read more →

Italian Medicines Agency approves reimbursed access to Bylvay (odevixibat) for patients with all PFIC types

6 September 2022 - Positive Agenzia Italiana del Farmaco (AIFA) decision provides reimbursed access to the first medicine available for the ...

Read more →

Recell System insurance coverage begins in Japan for treatment of acute burns

1 September 2022 - Reimbursement in Japan will be similar to that of pricing in the United States. ...

Read more →

Pear Therapeutics and SelectHealth announce coverage to provide access to FDA authorised prescription digital therapeutic for the treatment of opioid use disorder

8 August 2022 - SelectHealth teams with Pear to provide its members with covered access to Pear’s innovative prescription digital therapeutic, ...

Read more →

HLS announces that Vascepa is now reimbursed by Ontario's Provincial Drug Plan

25 July 2022 - Reimbursement for Vascepa in Canada is now at more than 65% for publicly covered lives and private ...

Read more →

Ultra-expensive SMA drug Zolgensma to get insurance benefits from August

21 July 2022 - Novartis' Zolgensma (onasemnogene abeparvovec), the world's most expensive drug yet to treat spinal muscular atrophy, will ...

Read more →

German Government announces bill to drastically slash drug reimbursement

19 July 2022 - On 8 July 2022, the German Health Ministry has officially shared the second edition of a new ...

Read more →

Canada making progress in prescription drug coverage

13 July 2022 - Canada has seen a significant improvement in the number of Canadians eligible for some form of prescription ...

Read more →

Illuccix reimbursement milestone and launch updates: pass-through status granted in the U.S.

30 May 2022 - Telix Pharmaceuticals today provides an update on the U.S. and Australian launch and reimbursement status for ...

Read more →

Digital health devices must prove a benefit to get reimbursement

13 May 2022 - Digital health care companies should prove that their devices can improve the quality of patient care ...

Read more →

Aadi Bioscience announces unique permanent J code issued for Fyarro from Centers for Medicare and Medicaid Services

4 May 2022 - Effective 1 July J code will enable a streamlined reimbursement process for Fyarro. ...

Read more →

UnitedHealthcare restricts coverage of Aduhelm, following Medicare

2 May 2022 - UnitedHealthcare is restricting insurance coverage of Aduhelm across all of its health plans, saying the drug ...

Read more →

Digital Medicine Society launches toolkit to support reimbursement for new drugs developed using digital outcomes

4 April 2022 - New essential resources ensure that patients will benefit without delay following regulatory acceptance of digital outcomes. ...

Read more →

Bluebird Bio has serious cash flow concerns; inability to strike reimbursement deals in Europe partly to blame

3 April 2022 - Bluebird bio is a highly innovative biotechnology company which develops gene therapies for several rare genetic ...

Read more →

Valeo Pharma secures additional public reimbursement for Redesca, Enerzair Breezhaler and Atectura Breezhaler

22 March 2022 - Canadian provincial public reimbursement now complete for Redesca with the addition of British Columbia. ...

Read more →